Vasomotor symptoms and cardiovascular risk

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 32-35

  Gambacciani, M ^a   Pepe, A ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

CARDIOVASCULAR RISK; MENOPAUSE; VASOMOTOR SYMPTOMS

Indexed keywords

ANTIOXIDANT ACTIVITY; ARTERY CALCIFICATION; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLIMACTERIUM; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPERTENSION; MENOPAUSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPATHETIC NERVE; VASOMOTOR DISORDER; ADRENERGIC SYSTEM; BLOOD; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; METABOLISM; PATHOPHYSIOLOGY; POSTMENOPAUSE; REVIEW; RISK FACTOR;

ANTIOXIDANT; CHOLESTEROL;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CLIMACTERIC; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; POSTMENOPAUSE; RISK FACTORS; VASOMOTOR SYSTEM;

EID: 73949086562     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130903013445     Document Type: Article

References (33)

1. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210
2. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-41 (Pubitemid 32003509)
3. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63
4. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13 (Pubitemid 28502636)
5. Rossouw JE, Anderson G, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33 (Pubitemid 34761611)
6. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-602 (Pubitemid 46961004)
7. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77 (Pubitemid 46556472)
8. Gambacciani M. New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women. Endocrine 2004;24:231-8 (Pubitemid 41271154)
9. Leal M, Diaz J, Serrano E, Abellan J, Carbonell LF. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 2000;95:804-9
10. van der Schouw YT, Grobbee DE. Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy. Eur Heart J 2005;26:1358-61 (Pubitemid 41373511)
11. Gast GC, Grobbee DE, Pop VJ, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008;51:1492-8
12. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-40
13. Brown D, Sievert LL, Aki SL, et al. Effects of age, ethnicity and menopause on ambulatory blood pressure: Japanese-American and Caucasian school teachers in Hawaii. Am J Hum Biol 2001;13:486-93 (Pubitemid 32590931)
14. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 2007;14:308-15 (Pubitemid 46673483)
15. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74 (Pubitemid 20106689)
16. World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization, 2002. Available at: http://www.who.int/whr/2002
17. Villecco AS, de Aloysio D, Pilati G, et al. Noninvasive 24-hr monitoring of high blood pressure in climacteric outpatients. Maturitas 1987;9:267-74 (Pubitemid 17163574)
18. Owens JF, Stoney CM, Matthews KA. Menopause status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993;88:2794-802 (Pubitemid 23360207)
19. Staessen JA, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997;11:507-14 (Pubitemid 27434779)
20. Tremollieres FA, Pouilles J-M, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999;142:415-23 (Pubitemid 29059501)
21. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641-6 (Pubitemid 19221308)
22. Van Beresteijn EC, Riedstra M, van der Wel A, Schouten EG, Burema J, Kok FJ. Habitual dietary calcium intake and blood pressure change around the menopause: a longitudinal study. Int J Epidemiol 1992;21:683-9
23. Portaluppi F, Pansini F, Manfredini R, Mollica G. Relative influence of menopausal status, age and body mass index on blood pressure. Hypertension 1997;29:976-9 (Pubitemid 27152468)
24. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004;43:918-23 (Pubitemid 38579888)
25. 2-Adrenergic mechanism in menopausal hot flashes. Obstet Gynecol 1990;76:573-8 (Pubitemid 20322054)
26. Freedman RR. Physiology of hot flashes. Am J Hum Biol 2001;13:453-64 (Pubitemid 32590928)
27. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332-7 (Pubitemid 28361490)
28. Martin KA, Manson JE. Approach to the patient with menopausal symptoms. J Clin Endocrinol Metab 2008;93:4567-75
29. Utian WH, Archer DF, Bachmann GS, et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 2008;15:584-602
30. Practice Committee of the American Society for Reproductive Medicine. Estrogen and progestogen therapy in postmenopausal women. Fertil Steril 2008;90(Suppl 5):S88-102
31. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease. Obstet Gynecol 2008;112:1189-92
32. Gompel A, Rozenberg S, Barlow DH, et al. The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas 2008;61:227-32
33. Pines A, Sturdee DW, Birkhäuser MH, et al. For the Board of the International Menopause Society IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181-94 (Pubitemid 46752441)